Athersys, Inc.

3201 Carnegie Avenue
44115-2634 Cleveland
USA

Contact

About Athersys

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life.

Product portfolio of Athersys

Product portfolio

Show all

News about Athersys

03-Feb-2012 | business & finance

Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development

Funding supports advancement for treatment of neurological and cardiovascular conditions & advanced manufacturing platform

Read news

27-Sep-2010 | research and development

Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell ...

Read news

Show more news about Athersys

Get the life science industry in your inbox

Athersys, Inc.

About Athersys

Product portfolio of Athersys

Product portfolio

News about Athersys

Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development

Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

Here you will find Athersys, Inc.

Athersys, Inc.